Need Help?
16 March 2026
Cancers | Feature Papers from the First Half of 2025 in the “Cancer Therapy” Section
As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the first half of 2025 in the “Cancer Therapy” Section, which are listed below:
1. “Triple-Negative Breast Cancer Progression and Drug Resistance in the Context of Epithelial–Mesenchymal Transition”
by Ewa Błaszczak, Paulina Miziak, Adrian Odrzywolski, Marzena Baran, Ewelina Gumbarewicz and Andrzej Stepulak
Cancers 2025, 17(2), 228; https://doi.org/10.3390/cancers17020228
Available online: https://www.mdpi.com/2072-6694/17/2/228
2. “Recent Advances in the Clinical Translation of Small-Cell Lung Cancer Therapeutics”
by Subhadeep Das and Shayak Samaddar
Cancers 2025, 17(2), 255; https://doi.org/10.3390/cancers17020255
Available online: https://www.mdpi.com/2072-6694/17/2/255
3. “Exploring the Role of SGLT2 Inhibitors in Cancer: Mechanisms of Action and Therapeutic Opportunities”
by Aparamita Pandey, Martín Alcaraz,Jr., Pasquale Saggese, Adriana Soto, Estefany Gomez, Shreya Jaldu, Jane Yanagawa and Claudio Scafoglio
Cancers 2025, 17(3), 466; https://doi.org/10.3390/cancers17030466
Available online: https://www.mdpi.com/2072-6694/17/3/466
4. “Inflammatory Myofibroblastic Tumor: An Updated Review”
by Joon Hyuk Choi
Cancers 2025, 17(8), 1327; https://doi.org/10.3390/cancers17081327
Available online: https://www.mdpi.com/2072-6694/17/8/1327
5. “BTK Is the Target That Keeps on Giving: A Review of BTK-Degrader Drug Development, Clinical Data, and Future Directions in CLL”
by Ross T. Salvaris, Jamie Brennan and Katharine L. Lewis
Cancers 2025, 17(3), 557; https://doi.org/10.3390/cancers17030557
Available online: https://www.mdpi.com/2072-6694/17/3/557
6. “Lipid Metabolism in Breast Cancer: From Basic Research to Clinical Application”
by Xiangyu Huang, Bowen Liu and Songjie Shen
Cancers 2025, 17(4), 650;https://doi.org/10.3390/cancers17040650
Available online: https://www.mdpi.com/2072-6694/17/4/650
7. “Exploring the Metabolic Impact of FLASH Radiotherapy”
by Febe Geirnaert, Lisa Kerkhove, Pierre Montay-Gruel, Thierry Gevaert, Inès Dufait and Mark De Ridder
Cancers 2025, 17(1), 133; https://doi.org/10.3390/cancers17010133
Available online: https://www.mdpi.com/2072-6694/17/1/133
8. “Predicting Response to Treatment and Survival in Advanced Ovarian Cancer Using Machine Learning and Radiomics: A Systematic Review”
by Sabrina Piedimonte, Mariam Mohamed, Gabriela Rosa, Brigit Gerstl and Danielle Vicus
Cancers 2025, 17(3), 336; https://doi.org/10.3390/cancers17030336
Available online: https://www.mdpi.com/2072-6694/17/3/336
9. “Prostate Cancer: A Journey Through Its History and Recent Developments”
by Hamza Mallah, Zania Diabasana, Sina Soultani, Ysia Idoux-Gillet and Thierry Massfelder
Cancers 2025, 17(2), 194; https://doi.org/10.3390/cancers17020194
Available online: https://www.mdpi.com/2072-6694/17/2/194
10. “Green Tea Components: In Vitro and In Vivo Evidence for Their Anticancer Potential in Colon Cancer”
by Federica Randisi, Gianpaolo Perletti, Emanuela Marras and Marzia Bruna Gariboldi
Cancers 2025, 17(4), 623; https://doi.org/10.3390/cancers17040623
Available online: https://www.mdpi.com/2072-6694/17/4/623
11. “Pheochromocytomas and Paragangliomas—Current Management”
by Adam Brewczyński, Agnieszka Kolasińska-Ćwikła, Beata Jabłońska and Lucjan Wyrwicz
Cancers 2025, 17(6), 1029; https://doi.org/10.3390/cancers17061029
Available online: https://www.mdpi.com/2072-6694/17/6/1029
12. “The PI3K/Akt/mTOR Signaling Pathway in Triple-Negative Breast Cancer: A Resistance Pathway and a Prime Target for Targeted Therapies”
by Ali Hassan and Corinne Aubel
Cancers 2025, 17(13), 2232; https://doi.org/10.3390/cancers17132232
Available online: https://www.mdpi.com/2072-6694/17/13/2232
13. “Unraveling the Burden of Pancreatic Cancer in the 21st Century: Trends in Incidence, Mortality, Survival, and Key Contributing Factors”
by Jakob Zottl, Christian Günther Sebesta, Elena Tomosel, Marie-Christine Sebesta and Christian Sebesta
Cancers 2025, 17(10), 1607; https://doi.org/10.3390/cancers17101607
Available online: https://www.mdpi.com/2072-6694/17/10/1607
14. “In the Era of Cardiovascular–Kidney–Metabolic Syndrome in Cardio-Oncology: From Pathogenesis to Prevention and Therapy”
by Vincenzo Quagliariello, Massimiliano Berretta, Irma Bisceglia, Ilaria Giacobbe, Martina Iovine, Matteo Barbato, Carlo Maurea, Maria Laura Canale, Andrea Paccone, Alessandro Inno et al.
Cancers 2025, 17(7), 1169; https://doi.org/10.3390/cancers17071169
Available online: https://www.mdpi.com/2072-6694/17/7/1169
15. “Revolutionizing MASLD: How Artificial Intelligence Is Shaping the Future of Liver Care”
by Nicola Pugliese, Arianna Bertazzoni, Cesare Hassan, Jörn M. Schattenberg and Alessio Aghemo
Cancers 2025, 17(5), 722; https://doi.org/10.3390/cancers17050722
Available online: https://www.mdpi.com/2072-6694/17/5/722
You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.
Cancers Editorial Office